Patent details

EN | LT

LT - Kristalinės 5-chlor-N4-[-2-(dimetilfosforil)fenil]-N2-{2-metoksi-4-[4-(4-metilpiperazin-1-il) piperidin-1-il]pirimidin-2,4-diamino formos

EN - CRYSTALLINE FORMS OF 5-CHLORO-N4-[-2-(DIMETHYLPHOSPHORYL) PHENYL]-N2-{2-METHOXY-4-[4-(4-METHYLPIPERAZIN-1-YL) PIPERIDIN-1-YL]PYRIMIDINE-2,4-DIAMINE

Legal status

Patent in force

Claims | Licences/Sublicenses

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	C07D 239/48	(2006.01)
		A61K 31/506	(2006.01)
		A61P 35/00	(2006.01)

European patent
(11)	Number of the document	3209647
(13)	Kind of document	T
(96)	European patent application number	15787846.3
	Date of filing the European patent application	2015-10-21
(97)	Date of publication of the European application	2017-08-30
(45)	Date of publication and mention of the grant of the patent	2020-06-03
(46)	Date of publication of the claims translation	2020-09-25

PCT application
(86)	Number	PCT/US2015/056701
	Date	2015-10-21

PCT application publication
(87)	Number	WO 2016/065028
	Date	2016-04-28

Priority applications
(30)	Number	Date	Country code
	201462066849 P	2014-10-21	US

Inventors
(72)	ROZAMUS, Leonard, W., US SHARMA, Pradeep, US

Grantee
(73)	Takeda Pharmaceutical Company Limited , 1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi, Osaka, JP

Attorney or representative
(74)

Title
(54)	Kristalinės 5-chlor-N4-[-2-(dimetilfosforil)fenil]-N2-{2-metoksi-4-[4-(4-metilpiperazin-1-il) piperidin-1-il]pirimidin-2,4-diamino formos
	CRYSTALLINE FORMS OF 5-CHLORO-N4-[-2-(DIMETHYLPHOSPHORYL) PHENYL]-N2-{2-METHOXY-4-[4-(4-METHYLPIPERAZIN-1-YL) PIPERIDIN-1-YL]PYRIMIDINE-2,4-DIAMINE

Last renewal fee
	Payment date	Validity (years)	Amount
	2025-09-23	11	289.00 EUR

Next renewal fee
	2026-10-21